Curative effects and its related factors of lacrimal duct intubation with double tube under lacrimal endoscope for treating chronic dacryocystitis

中国实用眼科杂志 Pub Date : 2017-09-10 DOI:10.3760/CMA.J.ISSN.1006-4443.2017.09.004

Meng Xu, F. Xiao, Da Wang

{"title":"Curative effects and its related factors of lacrimal duct intubation with double tube under lacrimal endoscope for treating chronic dacryocystitis","authors":"Meng Xu, F. Xiao, Da Wang","doi":"10.3760/CMA.J.ISSN.1006-4443.2017.09.004","DOIUrl":null,"url":null,"abstract":"Objective \nTo explore the clinical curative effects and its related factors of lacrimal duct intubation with double tube under lacrimal endoscope for treating chronic dacryocystitis. \n \n \nMethods \nFrom January 2013 to May 2014, 139 patients (152 eyes) with chronic dacryocystitis received lacrimal duct intubation with double tube under lacrimal endoscope were collected from department of ophthalmology of the fourth people’s hospital of Shenyang. Gender, age, course, extubation time and curative effect were recorded. Statistics were used to analyze the relevant factors. The final data using Mann-Whitney rank test or Spearman correlation test. \n \n \nResults \nAfter postoperative follow-up 6~12 months, 139 cases (152 eyes) in patients with chronic dacryocystitis cured 130 eyes (85.5%), improvement in 8 eyes (5.3%), invalid 14 eyes (9.2%), the total effective rate was 90.8%. All patients had no obvious complications. Single factor analysis showed that the curative effects in patients with different gender and different course had no statistical significance (P >0.05), while in patients with different ages, different extubation sequence and different extubation time the difference all had statistical significance. \n \n \nConclusions \nThe curative rate of lacrimal duct intubation with double tube under lacrimal endoscope for treating chronic dacryocystitis is high without obvious complication. Preoperative fully consider the impact on curative effects in patients of different ages, and after extubation regularly followed-up and strictly control the extubation order and extubation time, it can further improve the success rate. \n \n \nKey words: \nLacrimal endoscope; Lacrimal duct intubation with double tube; Chronic dacryocystitis","PeriodicalId":10236,"journal":{"name":"中国实用眼科杂志","volume":"1 1","pages":"860-864"},"PeriodicalIF":0.0000,"publicationDate":"2017-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国实用眼科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1006-4443.2017.09.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Objective To explore the clinical curative effects and its related factors of lacrimal duct intubation with double tube under lacrimal endoscope for treating chronic dacryocystitis. Methods From January 2013 to May 2014, 139 patients (152 eyes) with chronic dacryocystitis received lacrimal duct intubation with double tube under lacrimal endoscope were collected from department of ophthalmology of the fourth people’s hospital of Shenyang. Gender, age, course, extubation time and curative effect were recorded. Statistics were used to analyze the relevant factors. The final data using Mann-Whitney rank test or Spearman correlation test. Results After postoperative follow-up 6~12 months, 139 cases (152 eyes) in patients with chronic dacryocystitis cured 130 eyes (85.5%), improvement in 8 eyes (5.3%), invalid 14 eyes (9.2%), the total effective rate was 90.8%. All patients had no obvious complications. Single factor analysis showed that the curative effects in patients with different gender and different course had no statistical significance (P >0.05), while in patients with different ages, different extubation sequence and different extubation time the difference all had statistical significance. Conclusions The curative rate of lacrimal duct intubation with double tube under lacrimal endoscope for treating chronic dacryocystitis is high without obvious complication. Preoperative fully consider the impact on curative effects in patients of different ages, and after extubation regularly followed-up and strictly control the extubation order and extubation time, it can further improve the success rate. Key words: Lacrimal endoscope; Lacrimal duct intubation with double tube; Chronic dacryocystitis

查看原文本刊更多论文

泪道内窥镜下双管泪道插管治疗慢性泪囊炎的疗效及相关因素分析

目的探讨泪道内窥镜下双管泪道插管治疗慢性泪囊炎的临床疗效及其影响因素。方法收集2013年1月至2014年5月沈阳市第四人民医院眼科在泪道内窥镜下行双管泪道插管治疗的慢性泪囊炎患者139例(152眼)。记录患者性别、年龄、疗程、拔管时间及疗效。采用统计学方法对相关因素进行分析。最终数据采用Mann-Whitney秩次检验或Spearman相关检验。结果经术后随访6~12个月，139例(152眼)慢性泪囊炎患者治愈130眼(85.5%)，好转8眼(5.3%)，无效14眼(9.2%)，总有效率90.8%。所有患者均无明显并发症。单因素分析显示，不同性别、不同病程患者的疗效差异无统计学意义(P < 0.05)，而不同年龄、不同拔管顺序、不同拔管时间患者的疗效差异均有统计学意义。结论泪道内窥镜下双管泪道插管治疗慢性泪囊炎治愈率高，无明显并发症。术前充分考虑不同年龄患者对疗效的影响，拔管后定期随访，严格控制拔管顺序和拔管时间，可进一步提高成功率。关键词:泪道内窥镜;双管泪道插管;慢性泪囊炎

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

中国实用眼科杂志

自引率

0.00%

发文量

9101

期刊介绍： China Practical Ophthalmology was founded in May 1983. It is supervised by the National Health Commission of the People's Republic of China, sponsored by the Chinese Medical Association and China Medical University, and publicly distributed at home and abroad. It is a national-level excellent core academic journal of comprehensive ophthalmology and a series of journals of the Chinese Medical Association. China Practical Ophthalmology aims to guide and improve the theoretical level and actual clinical diagnosis and treatment ability of frontline ophthalmologists in my country. It is characterized by close integration with clinical practice, and timely publishes academic articles and scientific research results with high practical value to clinicians, so that readers can understand and use them, improve the theoretical level and diagnosis and treatment ability of ophthalmologists, help and support their innovative development, and is deeply welcomed and loved by ophthalmologists and readers.